National Institutes of Health

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing July 2, 2027.